← All trials
NCT00478439
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2007
- Primary completion
- Sep 30, 2009
- Completion date
- Oct 31, 2010
- First posted
- May 24, 2007
- Last posted
- Oct 27, 2010
- Enrollment
- 13
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Alabama, BirminghamLead sponsor
- University of Alabama, BirminghamSponsor investigator
- University of Alabama, BirminghamOverall official - principal investigator
- ZeaVision, Inc.Collaborator
- University of Alabama, BirminghamOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.